Across the recent three months, 7 analysts have shared their insights on Moderna (NASDAQ:MRNA), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 3 | 3 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 2 | 0 | 0 |
| 3M Ago | 1 | 1 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $123.43, a high estimate of $231.00, and a low estimate of $69.00. Highlighting a 21.76% decrease, the current average has fallen from the previous average price target of $157.75.
Investigating Analyst Ratings: An Elaborate Study
An in-depth analysis of recent analyst...
Login or create a forever free account to read this news
Sign up/Log in